(Q80595803)
Statements
Phase 1 study of lonafarnib (SCH 66336) and imatinib mesylate in patients with chronic myeloid leukemia who have failed prior single-agent therapy with imatinib (English)
Jorge Cortes
Elias Jabbour
Susan O'Brien
Alessandra Ferrajoli
Charles Koller
Yali Zhu
Paul Statkevich
Hagop Kantarjian